Global GERD Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Administration Route;

Oral and Parenteral.

By Drug Type;

Proton Pump Inhibitors (PPIs), H2 Receptor Blockers, and Others.

By Diagnosis;

Upper Endoscopy, Ambulatory Acid (pH) Probe Test, Esophageal Manometry, and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn397919948 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global GERD Market (USD Million), 2021 - 2031

In the year 2024, the Global GERD Market was valued at USD 5,413.00 million. The size of this market is expected to increase to USD 6,098.08 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 1.7%.

The global GERD (Gastroesophageal Reflux Disease) market is experiencing steady growth, driven by the increasing prevalence of GERD, changes in lifestyle, dietary habits, and the rising awareness about the condition. GERD is becoming more common due to factors like obesity, smoking, and poor eating habits, leading to a surge in demand for treatments such as proton pump inhibitors (PPIs), H2 receptor blockers, and other medications. The market is also witnessing advancements in minimally invasive surgical procedures and endoscopic treatments, offering patients new options for managing severe cases of GERD. As more people are diagnosed with GERD, there is a corresponding rise in demand for both pharmaceutical and surgical interventions.

North America holds the largest market share, owing to the high prevalence of GERD in the United States and Canada, along with the presence of advanced healthcare infrastructure and a wide range of treatment options. Europe follows closely behind, with countries like Germany, France, and the UK showing significant demand for GERD treatments. However, the Asia-Pacific region is emerging as a high-growth market, driven by urbanization, dietary changes, and increasing healthcare access in countries such as China and India. The expanding middle class and rising awareness about GERD in these regions create a favorable environment for market growth, while Latin America and the Middle East & Africa are also gradually witnessing a rise in the demand for GERD treatments due to improving healthcare infrastructure.

Despite the positive growth outlook, the GERD market faces challenges such as high treatment costs in developing regions, particularly for advanced therapies and surgeries. Additionally, the long-term use of GERD medications, such as PPIs, raises concerns about safety and side effects, leading to growing interest in alternative treatments. However, emerging opportunities in the market include the expansion of healthcare infrastructure in developing regions, which provides greater access to GERD treatments, and innovations in drug development and surgical procedures. As more people gain access to affordable and effective therapies, the GERD market is expected to continue evolving, with significant advancements in both pharmacological and surgical treatments.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Administration Route
    2. Market Snapshot, By Drug Type
    3. Market Snapshot, By Diagnosis
    4. Market Snapshot, By Region
  4. Global GERD Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of GERD

        2. Rising demand for GERD medications

        3. Growing awareness and early diagnosis

        4. Advancements in surgical treatments

      2. Restraints
        1. Side effects and long-term safety concerns
        2. Availability of alternative treatments
        3. High treatment costs in developing regions
      3. Opportunities
        1. Development of novel therapeutics
        2. Adoption of telemedicine and online pharmacies
        3. Focus on personalized medicine
        4. Expanding healthcare infrastructure in emerging markets
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global GERD Market, By Administration Route, 2021 - 2031 (USD Million)
      1. Oral
      2. Parenteral
    2. Global GERD Market, By Drug Type, 2021 - 2031 (USD Million)
      1. Proton Pump Inhibitors (PPIs)
      2. H2 Receptor Blockers
      3. Others
    3. Global GERD Market, By Diagnosis, 2021 - 2031 (USD Million)
      1. Upper Endoscopy
      2. Ambulatory Acid (pH) Probe Test
      3. Esophageal Manometry
      4. Others
    4. Global GERD Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. AstraZeneca
      2. Eisai
      3. GSK
      4. Johnson & Johnson
      5. Takeda
  7. Analyst Views
  8. Future Outlook of the Market